NSCLC患者使用ICIs时发生免疫相关不良事件的危险因素及与疗效的关系
徐金慧, 续广娟, 段露芬, 刘凯丽, 周琴, 孙坚彤, 丁信园
The risk factor analysis for immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint inhibitors and their relationship to effectiveness
XU Jinhui, XU Guangjuan, DUAN Lufen, LIU Kaili, ZHOU Qin, SUN Jiantong, DING Xinyuan
天津医药
.
2023, (2): 207
-212
.
DOI: 10.11958/20221393
